
Roberto Salvatori
Medical Director, Johns Hopkins Pituitary Center · Johns Hopkins University School of Medicine
Credentials: · · ·
History
- Present
Johns Hopkins Pituitary Center · Johns Hopkins University School of Medicine
- 1988–1990
Endocrinology, Diabetes, and Metabolism
- 1985–1988
Internal Medicine
- 1981–1985
Doctor of Medicine
Research
Consensus on diagnosis and management of Cushing's disease: a guideline update
Review · The Lancet Diabetes & Endocrinology · 2021 · 765 citations
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
The Journal of Clinical Endocrinology & Metabolism · 2016 · 678 citations
Review · Nature Reviews Endocrinology · 2023 · 317 citations

19 papers · 14 as a resident

17 papers

16 papers
- MF
16 papers

12 papers · 1 as a fellow
- GW
12 papers
- DM
11 papers · 2 as a resident

10 papers
Grants
- 2004–2009
Consequences of Lifetime Isolated Growth Hormone Deficiency
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.1M · Johns Hopkins University
- 2006–2009
Creation of a Mouse Model of Isolated GH Deficiency
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $443.3K · Johns Hopkins University
- 2004–2006
Consequences of Generalized Lack of GHRH
National Institute of Child Health and Human Development · R03
Contact PI · $163.5K · Johns Hopkins University
- 2003–2005
Molecular Analysis of GHRH Receptor Missense Mutations
National Institute of Child Health and Human Development · R03
Contact PI · $163.5K · Johns Hopkins University
Clinical trials
- 2005–2007
Anterior Pituitary Function in Patients With Hydrocephalus
Principal investigator · Terminated
Johns Hopkins University
- 2005–2009
Consequence of Lifetime Isolated Growth Hormone Deficiency
Principal investigator · Completed
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2018–2027
Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Sub-investigator · Recruiting · Phase 2
Johns Hopkins University


